These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9728364

  • 1. The neuropathology of organ transplantation: comparison and contrast in 500 patients.
    Martínez AJ.
    Pathol Res Pract; 1998; 194(7):473-86. PubMed ID: 9728364
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center.
    Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA.
    Transplantation; 1993 Jul; 56(1):88-96. PubMed ID: 8333073
    [Abstract] [Full Text] [Related]

  • 3. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 4. Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
    Gao SZ, Chaparro SV, Perlroth M, Montoya JG, Miller JL, DiMiceli S, Hastie T, Oyer PE, Schroeder J.
    J Heart Lung Transplant; 2003 May; 22(5):505-14. PubMed ID: 12742411
    [Abstract] [Full Text] [Related]

  • 5. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Belchis DA, Tomaszewski JE.
    Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
    [Abstract] [Full Text] [Related]

  • 6. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, de Ville de Goyet J, Reding R, Janssen M, Buts JP, Otte JB.
    Transplantation; 1997 Nov 27; 64(10):1438-42. PubMed ID: 9392308
    [Abstract] [Full Text] [Related]

  • 7. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V.
    Clin Transplant; 1996 Jun 27; 10(3):248-55. PubMed ID: 8826661
    [Abstract] [Full Text] [Related]

  • 8. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 27; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 9. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N, Büchler M, Foucher Y, Moreau A, Debiais C, Machet MC, Kessler M, Morelon E, Thierry A, Legendre C, Rivalan J, Kamar N, Dantal J.
    Transpl Int; 2014 Sep 27; 27(9):956-65. PubMed ID: 24964147
    [Abstract] [Full Text] [Related]

  • 10. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
    Wójciak M, Gozdowska J, Dęborska-Materkowska D, Perkowska-Ptasińska A, Kosieradzki M, Nazarewski S, Durlik M.
    Transplant Proc; 2018 Sep 27; 50(7):2154-2158. PubMed ID: 30177129
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan 27; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 12. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 13. Management of post-transplant lymphoproliferative disorders.
    DeStefano CB, Desai SH, Shenoy AG, Catlett JP.
    Br J Haematol; 2018 Aug 27; 182(3):330-343. PubMed ID: 29741774
    [Abstract] [Full Text] [Related]

  • 14. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 27; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 15. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL.
    Clin Transplant; 1995 Feb 27; 9(1):53-9. PubMed ID: 7742583
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus infections in children after transplantation of the small intestine.
    Finn L, Reyes J, Bueno J, Yunis E.
    Am J Surg Pathol; 1998 Mar 27; 22(3):299-309. PubMed ID: 9500771
    [Abstract] [Full Text] [Related]

  • 17. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
    Gheorghe G, Radu O, Milanovich S, Hamilton RL, Jaffe R, Southern JF, Ozolek JA.
    Pediatr Dev Pathol; 2013 Mar 27; 16(2):67-73. PubMed ID: 23286282
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.
    J Heart Lung Transplant; 2015 Nov 27; 34(11):1406-14. PubMed ID: 26279197
    [Abstract] [Full Text] [Related]

  • 19. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M, Marciano S, dos Santos Schraiber L, Zapata R, Quiros R, Zanotelli ML, Rivas MM, Kusminsky G, Humeres R, Alves de Mattos A, Gadano A, Silva MO.
    Clin Transplant; 2013 Nov 01; 27(4):E469-77. PubMed ID: 23758407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.